Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kawahara, Takuya"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L.
    Autorzy:
    Izumi S; Biostatistics and Bioinformatics Course, Graduate School of Interdisciplinary Information Studies, The University of Tokyo, Tokyo, Japan.
    Hagiwara Y; Department of Biostatistics, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .
    Matsuyama Y; Department of Biostatistics, School of Public Health, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
    Shiroiwa T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
    Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
    Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
    Konomura K; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
    Noto S; Center for Health Economics and QOL Research, Niigata University of Health and Welfare, Niigata, Japan.
    Fukuda T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
    Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
    Pokaż więcej
    Źródło:
    Health and quality of life outcomes [Health Qual Life Outcomes] 2023 Jan 17; Vol. 21 (1), pp. 3. Date of Electronic Publication: 2023 Jan 17.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial
    MeSH Terms:
    Neoplasms*
    Quality of Life*
    Surveys and Questionnaires*
    Humans ; Reproducibility of Results
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework.
    Autorzy:
    Sakamaki K; Center for Data Science, Yokohama City University, 22-2 Seto, Kanazawa-ku, Yokohama, 236-0027, Japan. .
    Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    BMC medical research methodology [BMC Med Res Methodol] 2022 Oct 04; Vol. 22 (1), pp. 259. Date of Electronic Publication: 2022 Oct 04.
    Typ publikacji:
    Journal Article; Review; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Neoplasms*/therapy
    Quality of Life*
    Humans ; Medical Oncology ; Patient Reported Outcome Measures ; Research Design
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
    Autorzy:
    Hagiwara Y; Department of Biostatistics, Division of Health Sciences and Nursing, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .
    Shiroiwa T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
    Taira N; Breast and Endocrine Surgery Department, Okayama University Hospital, Okayama, Japan.
    Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
    Konomura K; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
    Noto S; Center for Health Economics and QOL Research, Niigata University of Health and Welfare, Niigata, Japan.
    Fukuda T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
    Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
    Pokaż więcej
    Źródło:
    Health and quality of life outcomes [Health Qual Life Outcomes] 2020 Nov 03; Vol. 18 (1), pp. 354. Date of Electronic Publication: 2020 Nov 03.
    Typ publikacji:
    Journal Article; Validation Study
    MeSH Terms:
    Quality of Life*
    Neoplasms/*psychology
    Surveys and Questionnaires/*standards
    Adult ; Aged ; Algorithms ; Female ; Humans ; Japan ; Logistic Models ; Male ; Middle Aged
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Autorzy:
    Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. .
    Shinozaki T; Department of Information and Computer Technology, Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan.
    Matsuyama Y; Department of Biostatistics, School of Public Health, The University of Tokyo, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    BMC medical research methodology [BMC Med Res Methodol] 2020 Jul 31; Vol. 20 (1), pp. 204. Date of Electronic Publication: 2020 Jul 31.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Pravastatin*/therapeutic use
    Primary Prevention*
    Computer Simulation ; Humans ; Models, Statistical ; Probability ; Survival Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.
    Autorzy:
    Shiroiwa T; Department of Health and Welfare Services, National Institute of Public Health, 2-3-6 Minami, Wako, Saitama, 351-0197, Japan. .
    Fukuda T; Department of Health and Welfare Services, National Institute of Public Health, 2-3-6 Minami, Wako, Saitama, 351-0197, Japan.
    Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, 1-1-1 Noji-higashi, Kusatsu, Shiga, 525-8577, Japan.
    Mouri M; Kanagawa Academy of Science and Technology (KAST), 3-2-1 Sakado, Takatsu-ku, Kawasaki, Kanagawa, 213-0012, Japan.
    Hagiwara Y; Department of Biostatistics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
    Kawahara T; Department of Biostatistics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
    Ohsumi S; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-machi, Matsuyama, Ehime, 791-0280, Japan.
    Hozumi Y; Department of Breast and Endocrine Surgery, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan.; Department of Breast Surgery, Ibaraki Prefectural Central Hospital, 6528 Koibuchi, Kasama, Ibaraki, 309-1793, Japan.
    Sagara Y; Breast Surgery Department, Social Medical Corporation Hakuaikai Sagara Hospital, Matsubara-cho 3-31, Kagoshima, 892-0833, Japan.
    Ohashi Y; Department of Integrated Science and Engineering, Chuo University, 1-13-27 Kasuga, Bunkyo-ku, Tokyo, 112-8551, Japan.
    Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2017 Nov 17; Vol. 17 (1), pp. 773. Date of Electronic Publication: 2017 Nov 17.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cost-Benefit Analysis*
    Antimetabolites, Antineoplastic/*therapeutic use
    Breast Neoplasms/*drug therapy
    Breast Neoplasms/*epidemiology
    Oxonic Acid/*therapeutic use
    Tegafur/*therapeutic use
    Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Biomarkers, Tumor ; Breast Neoplasms/pathology ; Clinical Trials, Phase III as Topic ; Drug Combinations ; Female ; Humans ; Japan ; Neoplasm Metastasis ; Neoplasm Staging ; Oxonic Acid/administration & dosage ; Oxonic Acid/adverse effects ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic ; Tegafur/administration & dosage ; Tegafur/adverse effects ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies